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Abstract
Background: In sub-Saharan Africa, the distributions of malaria and HIV widely overlap. Among pregnant and non-
pregnant adults, HIV affects susceptibility to malaria, its clinical course and impairs antibody responses to malaria
antigens. However, the relationship between the two diseases in childhood, when most deaths from malaria occur,
is less clear. It was previously reported that HIV is associated with admission to hospital in rural Kenya with severe
malaria among children, except in infancy. HIV-infected children with severe malaria were older, had higher
parasite density and increased mortality, raising a hypothesis that HIV interferes with naturally acquired immunity
to malaria, hence with little effect at younger ages (a shorter history of exposure). To test this hypothesis, levels of
anti-merozoite and schizont extract antibodies were compared between HIV-infected and uninfected children who
participated in the original study.
Methods: IgG responses to malaria antigens that are potential targets for immunity to malaria (AMA1, MSP2, MSP3
and schizont extract) were compared between 115 HIV-infected and 115 age-matched, HIV-uninfected children
who presented with severe malaria. The children were classified as high and low responders for each antigen and
assigned antibody-response breadth scores according to the number of antigens to which they were responsive.
A predictive logistic regression model was used to test if HIV was an effect modifier on the age-related acquisition
of antibody responses, with age as a continuous variable.
Results: Point estimates of the responses to all antigens were lower amongst HIV-infected children, but this was only
statistically significant for AMA1 (P = 0.028). HIV-infected children were less likely to be high responders to AMA1 [OR
0.44 (95%CI, 0.2-0.90) P = 0.024]. HIV was associated with a reduced breadth of responses to individual merozoite
antigens (P = 0.02). HIV strongly modified the acquisition of antibodies against schizont extract with increasing age
(P < 0.0001), but did not modify the rate of age-related acquisition of responses to individual merozoite antigens.
Conclusions: In children with severe malaria, HIV infection is associated with a lower magnitude and narrower
breadth of IgG responses to merozoite antigens and stunting of age-related acquisition of the IgG antibody
response to schizont extract.
Background
HIV and malaria are major causes of morbidity and
mortality in sub-Saharan Africa [1]. Within the region,
there is widespread overlap in the distribution of the
two diseases [2]. Thus, any interaction between the two
diseases may have potentially important public health
implications.
There is evidence that HIV infection influences sus-
ceptibility to, and the clinical course of malaria. Studies
in non-pregnant [3-7] and pregnant adults [8-10] sug-
gest that HIV infection is associated with more frequent
episodes of clinical malaria and higher parasite density.
However, reports of the effects of HIV on malaria in
childhood, when most malaria deaths occur, have been
inconsistent.
Naturally acquired immunity to malaria is dependent
on exposure. Thus, in malaria endemic areas, immunity
to severe disease, mild disease and parasitaemia
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normally increases with age [11,12]. A recent report
from Kilifi, Kenya suggested that HIV infection is asso-
ciated with hospital admission for severe malaria among
children [13]. Importantly, those infected with HIV were
older (median age, 38 months; IQR, 26-63 months) than
those without HIV infection (median age, 19 months;
IQR, 10-35 months; P < 0.001). HIV-infected children
had higher peripheral parasite density when corrected
for age. Despite the overall strong association between
HIV infection and severe malaria, there was no relation-
ship between HIV and severe malaria in infancy [13].
This raised the hypothesis that HIV might stunt the
age-related acquisition of natural immunity to malaria,
thus having little effect among the youngest children
who have not yet acquired natural immunity to malaria.
Since both the breadth and magnitude of IgG antibody
responses to multiple Plasmodium falciparum merozoite
antigens have been associated with immunity to clinical
malaria [14], this study was conducted to investigate the
effects of HIV infection on the antibody response to
three merozoite antigens that are potential targets for
immunity to malaria: apical merozoite antigen 1
(AMA1), merozoite surface protein 2 (MSP2) and mero-
zoite surface protein 3 (MSP3); and whole parasite schi-
zont extract.
Methods
Location and study population
Kilifi District Hospital, Kenya, serves approximately
240,000 people in a rural, coastal area where malaria is
endemic (<1 to 120 mosquito bites are infective for
P. falciparum each year) [15]. This nested study was
conducted using plasma samples collected during a pro-
spective study undertaken between 1998 and 2002 [13].
The prevalence of HIV infection was 1.7% among chil-
dren sampled in the community during the study per-
iod, and 9.8% among women attending the hospital
antenatal clinic in 2000 [13]. At the time of the study
there were no specific HIV care services and conse-
quently no use of anti-retroviral drugs or co-trimoxazole
prophylaxis. This ‘natural history’ study would not now
be possible, because of the current widespread use of
these drugs. Approval for the study was given by the
Kenyan National Ethical Review Committee (SSC No.
502 and SCC No. 485) and individual written informed
consent was obtained.
Clinical data collection
Trained research clinicians provided care and collected
standardized clinical and laboratory data on all paedia-
tric admissions. Clinical features of severe malaria were
defined as either a history of febrile illness or an axillary
temperature ≥37.5°C on admission, plus one or more of
the following signs: impaired consciousness (the inability
to localize a painful stimulus if aged >8 months, or not
having directed eye movements if age ≤8 months), deep
breathing (Kussmaul’s respiration) or severe anaemia
(haemoglobin <5 g/dl) [13]. Children received supportive
care and anti-malarial treatment according to national
guidelines and WHO recommendations.
Malaria diagnosis was performed by examining
Giemsa-stained thick and thin blood-smears at x1,000
magnification. A full blood count was performed using
an MD2 automated counter (Beckman/Coulter, UK).
Peripheral parasite densities were calculated from each
child’s actual red and white cell counts. HIV testing
was done retrospectively by enzyme-linked immuno-
sorbent assay after delinking the samples from their
identity data; true infection was confirmed by polymer-
ase chain reaction for children aged <18 months
(Ampliclor; Roche). HIV infection was present in 133
(12%) of the 1,071 parasitaemic children with signs of
severe malaria[13].
Recombinant antigens
The recombinant MSP2 CH150/9 was expressed in
Escherichia coli [16]. MSP3 (full length) was expressed in
Escherichia coli [17]. Recombinant AMA1 (1:1 mixture of
FVO and 3d7) was expressed in Pichia pastoris [18].
Antibody assays
The study was conducted using stored plasma samples
taken at the time of admission with a diagnosis of severe
malaria from 115 HIV-infected children and 115 samples
randomly drawn from the larger set of HIV-uninfected
children matched on age and season (wet/dry) of admis-
sion to eliminate their potential confounding effects.
Enzyme-linked immunosorbent assays (ELISAs) on
antibodies against parasite schizont extract and recombi-
nant antigens AMA1, MSP2 and MSP3 were performed
as previously described [14]. Briefly, individual wells of
microtitre plates (Nunc) were coated with 50 ng of anti-
gen in 100 μl of carbonate coating buffer (15 mM
Na2CO3, 35 mM NaHCO3, pH 9.3). Alternatively,
microtitre plates were coated with P. falciparum schi-
zont extract (the A4 strain) in phosphate-buffered saline
(PBS) according to the method of Ndungu et al [19].
Plates were incubated overnight at 4°C before washing
three times in PBS-Tween (PBS-0.05% Tween 20) and
subsequently blocking for five hours at room tempera-
ture with 1% skimmed milk in PBS-Tween. Following
this, plates were washed four times and thereafter incu-
bated overnight at 4°C with 100 μl of test serum (1/500
dilution in blocking buffer). Plates were then washed
four times and then incubated for one hour at room
temperature with 100 μl of alkaline phosphatase conju-
gated goat antihuman IgG (Sigma) at 1/500 in blocking
buffer. They were then washed four times and
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subsequently incubated for 20 minutes at room tem-
perature with 50 μl of diluted p-nitrophenyl phosphate
(Sigma) for color development. The reaction was
stopped using 50 μl of 3 M NaOH. Optical densities
were measured at 405/570 nanometers.
A single adult hyper-immune serum, with an assigned
IgG antibody concentration in Arbitrary Units (AU),
was serially diluted and included in each plate. It was
later used to convert the optical density (OD) readings
of the samples into relative concentrations in AU,
thereby eliminating the effect of inter-plate and inter-
day variation.
Statistical analysis
The data were analysed with STATA version 11.0 (Stata
Corporation, TX, USA). P values < 0.05 were considered
as significant. The Chi squared test was used to compare
proportions. As antibody levels were skewed, the Wil-
coxon signed-ranks test for matched pairs was used to
compare antibody levels (AU) between children with and
without HIV infection. Each child was categorized as a
high or low responder to each antigen depending on
whether their antibody levels were above or below the
overall median. Conditional logistic regression, adjusted
for age, season, parasite density, haemoglobin and resi-
dence in the Northern or Southern part of the district
(the two areas have different malaria transmission inten-
sities[20]) was used to determine the odds of a child
being a high responder to each antigen. Breadth of mero-
zoite responses was assessed by assigning the children a
score on the basis of the number of antigens to which
they were high responders i.e. zero to three (response to
schizont extract was not included in the score). The Chi
squared test for trend was used to test the relationship
between breadth of response and HIV status.
To test if HIV infection was acting as an effect modi-
fier on the age-related acquisition of antibody response,
a predictive logistic regression model was used with the
probability of being a high responder as the dependent
variable and age (continuous) and HIV status as inde-
pendent variables according to the method of Garrett
[21] and adjusted for season, parasite density, haemoglo-
bin and residence in the Northern or Southern area.
This model estimated the probability of a child being a
high responder as age increased, stratified by HIV status.
The P value of the likelihood ratio test (LRT) for the
interaction of age*HIV status is reported.
Results
Characteristics of the study population
The median age of the HIV infected children included
in this analysis was 37 months (interquartile range
(IQR) of 25 to 59 months) and that of the age-matched
HIV uninfected children was 37 months (IQR 25 to
59 months). Two HIV-uninfected and four HIV-infected
children had concurrent bacteraemia. Eight HIV-unin-
fected and fourteen HIV-infected children died. There
were no significant differences between the two groups
with regard to nutritional status and the three main
clinical features of severe malaria (i.e. anaemia, uncon-
sciousness and deep breathing) (Table 1).
Antibodies to merozoite antigens and HIV infection status
The point estimates of levels of antibodies to all the
antigens tested were lower among HIV-infected chil-
dren. This was statistically significant for antibodies
against AMA1 (P = 0.028) but not for those against
MSP2 (P = 0.90), MSP3 (P = 0.09) or schizont extract
(P = 0.10) (Figure 1). HIV infected children were less
likely to be high responders to AMA1 [OR 0.44 (95%CI,
0.2-0.90) P = 0.024]. There was no significant difference
with regard to MSP2 [OR 0.68 (95%CI, 0.31-1.46) P =
0.32], MSP3 [OR 0.74 (95% CI, 0.34-1.59) P = 0.44] or
schizont extract [OR 0.67 (95% CI 0.36 - 1.57) P =
0.36]. HIV infection interfered with the breadth of anti-
body response to merozoite antigens. The proportion of
HIV infected children decreased as breadth score
increased (Chi squared test for trend P = 0.02, Figure 2).
HIV infection was a strong effect modifier on the age-
related acquisition of antibody response against the schi-
zont extract (LRT = 18.73, P < 0.0001), with no increase
in the probability of being a high responder against schi-
zont extract with increasing age among HIV-infected
children (Figure 3). However, there was no evidence for
effect modification by HIV on the age-related acquisition
of responses to the individual merozoite antigens: AMA1
(LRT = 0.67, P = 0.41), MSP2 (LRT = 0.43, P = 0.51) and
MSP3 (LRT = 0.26, P = 0.61). Thus, although the point
estimates of the probabilities of being a high responder
Table 1 Population characteristics
HIV-uninfected HIV-infected P value
N 115 115














Severely anaemic1 68 68 0.87
Unconscious2 39 45 0.47
Bacteraemia3 2 4 0.42
Deep acidotic breathing 27 24 0.58
Malnutrition4 30 34 0.61
Death 8 14 0.19
*Groups were matched on age.
1haemoglobin < 5 g/dl.
2inability to localize a painful stimulus for children aged 18 months or lack of
directed eye movements for infants aged <8 months.
3positive aerobic blood culture for pathogenic bacteria.
4severe underweight (weight-for-age z score, <3) or having kwashiorkor.
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were consistently lower among the HIV-infected chil-
dren, estimates of the probability of being a high respon-
der for these individual merozoite antigens increased
with age, regardless of the HIV status (Figure 3).
Discussion
This study suggests that HIV-infected children have
impaired ability to respond to multiple malaria antigens
and HIV modifies the age-related acquisition of antibodies
to P. falciparum whole parasite schizont extract. Thus,
HIV infection impairs both the magnitude and breadth of
antibody response. Since antibodies are important in
immunity to severe malaria [22], these results are compati-
ble with the previous epidemiological observations which
suggested that HIV stunts the age-related acquisition of
immunity to severe malaria (increased age, parasite density
and case fatality) [13]. The inconsistent findings of studies
of the association between HIV and malaria in children
may therefore reflect the fact that the observed effect of
HIV on malaria is likely to depend on both age and trans-
mission intensity.
The response to schizont extract is a reflection of the
total response to the many individual antigens in the
malaria parasite. As such, the observed effect modifica-
tion by HIV on the age-related acquisition of response
is likely to reflect the cumulative effect modification on
the acquisition of responses to many malaria antigens,
which might not be observed if the individual responses
are studied separately.
The stunting of age-related acquisition of antibodies
to malaria antigens by HIV observed in this study
Figure 1 Relative levels of antibody to malaria antigens among HIV-infected and HIV-uninfected children.
Figure 2 Breadth of response scores for three merozoite
antigens among HIV-infected and HIV-uninfected children. Chi
squared test for trend P = 0.02.
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parallels the impaired parity-dependent acquisition of
antibodies against the variant surface antigens associated
with placental malaria parasites reported among Mala-
wian HIV-infected pregnant women [23]. Consistent
with the results of this study the HIV-infected women
also had reduced antibodies against AMA1. Similarly,
among non-pregnant Zambian adults, HIV impaired the
antibody response to AMA1 but spared antibody
responses to MSP2 [24].
Previous studies among adults have reported that the
risk of malaria infection and severe disease rises with
increasing derangement of the immune system due to
HIV and is highest among individuals with the lowest
CD4 cells counts [3,7,25-27], suggesting that the inter-
action between HIV and malaria is immunological.
However, the mechanism by which HIV affects anti-
body responses to malaria is unclear. In more
advanced stages of HIV infection, malaria responses
are probably stunted along with the global stunting of
all immune responses. One possible specific mechan-
ism by which HIV could stunt IgG responses to para-
sites, including malaria, is through the HIV Nef, an
HIV viral protein, which accumulates in B cells and
prevents class switching of HIV and non-HIV
responses [28,29]. However, observations in this study
and the other studies cited above suggest that in the
earlier stages of infection, HIV also influences specific
malaria responses.
It can be argued that, in one sense, protection against
severe malaria had failed in all of these children since
they all had severe malaria. However, responses differed
between HIV-infected and uninfected children, suggest-
ing true differences in rapid antibody responses during
this severe episode. Furthermore, in the original study,
the HIV infected children had higher parasitaemia and
were more likely to die, suggesting that they were more
immunologically deficient in terms of their ability to
control the malaria episode.
The study was limited to three malaria merozoite anti-
gens and the whole parasite lysate. The effect of HIV on
the variant surface antigens (VSAs) and the remaining
thousands of malaria antigens, the majority of which are
yet to be expressed and purified into recombinant pro-
teins, remains unexplored. Additionally, the sample size
was restricted to the number of available HIV-infected
plasma samples from the parent study. There were no
Figure 3 Probability of being a high responder against the various antigens with increasing age. Blue represents HIV-uninfected children
while red represents HIV-infected children. Error bars indicate the 95% confidence intervals. LRT refers to the likelihood ratio test for the
interaction of age*HIV status in the logistic regression model.
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data on CD4 counts or HIV viral loads from the chil-
dren in this study.
Conclusions
In children with severe malaria, HIV infection is asso-
ciated with a lower magnitude and narrower breadth of
IgG responses to merozoite antigens and stunting of
age-related acquisition of antibody responses to schizont
extract. Further research should investigate fractionated
schizont extract to identify the most significant compo-
nents; the effect of HIV on avidity maturation; function-
ality of the antibodies; and the ability of HIV-infected
children to mount effective responses to current and
putative malaria vaccines.
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